# clm_354B7C6D61E5

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_net_income  
value: 1,236,300,000 United States dollar  
valid_from: 2011-09-30  
valid_to: 2012-03-31  
published: 2011-10-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_DDE62BAA81E2  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly net income: 1,236,300,000 United States dollar", as of 2011-09-30 (until 2012-03-31). Claim clm_354B7C6D61E5, https://asof.is/claim/clm_354B7C6D61E5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000119312511286084/0001193125-11-286084-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q3 FY2011, filed 2011-10-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000119312511286084/0001193125-11-286084-index.htm (primary, SEC EDGAR 10-Q Q3 FY2011, published 2011-10-28)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_net_income | 1,197,300,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_354B7C6D61E5](/claim/clm_354B7C6D61E5.md) | [clm_008FDC208224](/claim/clm_008FDC208224.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
